DiaMedica Therapeutics (DMAC) EBITDA (2018 - 2026)
DiaMedica Therapeutics' EBITDA came in at -$10.49 million for Q2 2026, compared with -$8 million a year earlier.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) EBITDA (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, DiaMedica Therapeutics reported EBITDA of -$39.17 million; for FY2025, it was -$34.35 million.
- Going back by year, EBITDA was -$26.64 million in FY2024, -$21.24 million in FY2023, -$13.98 million in FY2022 and -$13.62 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2018.
- Business Quant data shows DMAC's EBITDA at -$10.47 million (Q1 2026), -$9.2 million (Q4 2025) and -$9.02 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | DiaMedica Therapeutics | 521.46 Mn | 311.42 Mn | - | -10.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.49 Mn |
| Mar 31, 2026 | -10.47 Mn |
| Dec 31, 2025 | -9.20 Mn |
| Sep 30, 2025 | -9.02 Mn |
| Jun 30, 2025 | -8.00 Mn |
| Mar 31, 2025 | -8.13 Mn |
| Dec 31, 2024 | -8.41 Mn |
| Sep 30, 2024 | -7.24 Mn |
| Jun 30, 2024 | -5.95 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | -6.21 Mn |
| Sep 30, 2023 | -5.57 Mn |
| Jun 30, 2023 | -4.96 Mn |
| Mar 31, 2023 | -5.72 Mn |
| Dec 31, 2022 | -3.97 Mn |
| Sep 30, 2022 | -3.12 Mn |
| Jun 30, 2022 | -3.36 Mn |
| Mar 31, 2022 | -3.41 Mn |
| Dec 31, 2021 | -3.13 Mn |
| Sep 30, 2021 | -3.40 Mn |
API Access
DiaMedica Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=DMAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "DMAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=DMAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();